Timothy Wang, MD
Gastroenterology · New York, NYNPI 1154499218
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,000 of the $3,398 with a category attached, or 88.3%. Boehringer Ingelheim International GmbH accounts for 88.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $3,000 and has fallen 98.3% since, to $52 in 2025.
Across 11 payments — averaging $308.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$3K
- Globus Medical$240
- Johnson & Johnson$74
- Aimmune Therapeutics, Inc.$30
- Pentax Of America, Inc.$23
- Covidien LP$17
- plus $15 from 1 others
Across 1 payment — averaging $162,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$162K
What the payments were for
- Consulting fees$3,00088%
- Food & beverage$39812%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 1 | $3,000 |
| Globus Medical | 5 | $240 |
| Johnson & Johnson | 1 | $74 |
| Aimmune Therapeutics, Inc. | 1 | $30 |
| Pentax Of America, Inc. | 1 | $23 |
| Covidien LP | 1 | $17 |
| QOL Medical, LLC | 1 | $15 |
How this compares
$3,398 in reported general payments places this provider in the 60th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in New York
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
- Caterina Oneto ArayaNew York$610K
- Dana LukinNew York$491K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.